A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Jordi Rodon
Charlotte D. Jacobs
Quincy Chu
Eric K. Rowinsky
Arturo Lopez-Anaya
Chris H. Takimoto
Heather A. Wakelee
机构：
[1] Cancer Therapy and Research Center at The University of Texas Health Science Center,Institute for Drug Development
[2] Stanford University and Stanford Cancer Institute,Division of Oncology, Department of Medicine
[3] Eisai,undefined
[4] Inc.,undefined
[5] Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology,undefined
[6] Cross Cancer Institute,undefined
[7] University of Alberta,undefined
[8] Oncodrugs Consulting,undefined
[9] Forest Laboratories,undefined
[10] Inc.,undefined
[11] Ortho Biotech Oncology R&D/Johnson & Johnson,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Bexarotene; Carboplatin; Paclitaxel; Pharmacokinetics; Phase I;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：825 / 834
页数：9
相关论文
共 50 条
  • [1] A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)
    Rodon, Jordi
    Jacobs, Charlotte D.
    Chu, Quincy
    Rowinsky, Eric K.
    Lopez-Anaya, Arturo
    Takimoto, Chris H.
    Wakelee, Heather A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 825 - 834
  • [2] A PHASE I/II STUDY OF BEXAROTENE WITH WEEKLY PACLITAXEL AND CARBOPLATIN FOR THE TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Whyman, Jeremy D.
    Kebbekus, Peter E.
    Fink, Sarah K.
    Rigas, James R.
    Dragnev, Konstantin H.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S883 - S883
  • [3] A phase I/II study of bexarotene with carboplatin and weekly paclitaxel for the treatment of patients with advanced non-small cell lung cancer
    Dragnev, Konstantin H.
    Whyman, Jeremy D.
    Hahn, Cynthia K.
    Kebbekus, Peter E.
    Kokko, Sarah F.
    Bhatt, Sunil M.
    Rigas, James R.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (09) : 5531 - 5537
  • [4] Paclitaxel and carboplatin: A phase I study in advanced non-small cell lung cancer
    Paccagnella, A
    Favaretto, A
    Oniga, F
    Ossana, L
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 76 - 79
  • [5] Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer
    Okamoto, Isamu
    Miyazaki, Masaki
    Morinaga, Ryotaro
    Kaneda, Hiroyasu
    Ueda, Shinya
    Hasegawa, Yoshikazu
    Satoh, Taroh
    Kawada, Akira
    Fukuoka, Masahiro
    Fukino, Koichi
    Tanigawa, Takahiko
    Nakagawa, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (06) : 844 - 853
  • [6] Phase I and pharmacokinetic study of paclitaxel and irinotecan for patients with advanced non-small cell lung cancer
    Kasai, T
    Oka, M
    Soda, H
    Tsurutani, J
    Fukuda, M
    Nakamura, Y
    Kawabata, S
    Nakatomi, K
    Nagashima, S
    Takatani, H
    Fukuda, M
    Kinoshita, A
    Kohno, S
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (14) : 1871 - 1878
  • [7] Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)
    Yasushi Ono
    Mitsunori Hino
    Yuka Ueda
    Ryoko Kamizuru
    Masatoshi Omata
    Takashi Uehara
    Yosuke Tanaka
    Tomoyuki Soma
    Shoji Kudoh
    Medical Oncology, 2007, 24 : 402 - 406
  • [8] Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)
    Ono, Yasushi
    Hino, Mitsunori
    Ueda, Yuka
    Kamizuru, Ryoko
    Omata, Masatoshi
    Uehara, Takashi
    Tanaka, Yosuke
    Soma, Tomoyuki
    Kudoh, Shoji
    MEDICAL ONCOLOGY, 2007, 24 (04) : 402 - 406
  • [9] A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
    Heather A. Wakelee
    Gary Middleton
    David Dunlop
    Rodryg Ramlau
    Natasha Leighl
    Desiree Hao
    Arturo Lopez-Anaya
    Petr Zatloukal
    Charlotte D. Jacobs
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 815 - 824
  • [10] A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
    Wakelee, Heather A.
    Middleton, Gary
    Dunlop, David
    Ramlau, Rodryg
    Leighl, Natasha
    Hao, Desiree
    Lopez-Anaya, Arturo
    Zatloukal, Petr
    Jacobs, Charlotte D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 815 - 824
12345